Streetbeat News

Products Services

HOTH

Hoth Therapeutics shares rose following the announcement of positive data from the treatment of epidermal growth factor receptor inhibitor associated papulopustular eruptions using its novel therapeutic HT-001.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 12:24 pm

MDAI

Spectral AI has received an $850K award from the Medical Technology Enterprise Consortium to further develop its AI-driven DeepView SnapShot M for assessing battlefield burn wounds. This brings its total non-dilutive government funding to over $7 million.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 12:24 pm

BRCC

KDP

BRC shares have risen following the announcement of a long-term sales and distribution agreement with Keurig Dr Pepper for a new line of ready-to-drink Black Rifle Energy beverages.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 12:23 pm

LPCN

Lipocine Inc. announced that Phase 2 data on LPCN 2401 will be presented at the Obesity Society's Annual ObesityWeek conference in November 2024. The study focuses on participants with obesity and those with BMI ≥27 with weight-related comorbidities.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 12:23 pm

HOTH

Hoth Therapeutics has reported positive data for its drug HT-001 in treating EGFRI-associated papulopustular eruptions. A cancer patient was able to cease treatment after just one week due to rapid symptom resolution.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 12:22 pm

BTDR

Bitdeer Technologies Group (NASDAQ:BTDR) reported its August 2024 operations update, highlighting the mining of 166 Bitcoins and a decrease in client-hosted mining machines. The company is progressing with its SEALMINER A1 production and various datacenter expansions. Bitdeer also completed a $172.5 million convertible notes offering for expansion and development purposes.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 12:22 pm

SHLS

Shoals Technologies Group is hosting its first Investor Day, introducing long-term financial targets and strategies for profitable growth. The event will cover revenue diversification, innovative products, and capital allocation priorities.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 12:21 pm

PPTA

Perpetua Resources Corp. announced that the United States Forest Service has completed the final Environmental Impact Statement and issued a draft Record of Decision authorizing the Stibnite Gold Project.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 12:20 pm

CASH

ML

Pathward Financial and MoneyLion have extended their partnership for an additional three years, continuing their collaboration on the RoarMoney Demand Deposit Account through 2029.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 12:20 pm

LSTA

Lisata Therapeutics' drug, certepetide, has been granted Orphan Drug Designation by the FDA for treating cholangiocarcinoma, a type of cancer. This designation can provide benefits like market exclusivity and tax credits, potentially boosting Lisata's prospects.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 12:20 pm